Doris Peterkin is a biotech executive with over 25 years of experience in bringing novel biologics and medical devices from proof of concept to market. Since 2011, she has been CEO of OncoPep, an early clinical stage biotech developing novel, immunotherapies using a T cell driven mechanism for the treatment of hematological and solid tumor cancers. During this time she co-founded and served as CEO of medical device company Miach Orthopaedics. Previously, Doris was CEO of Healagenics, Inc. and held senior management roles at Antigenics (oncology biotech) and Genzyme. She is a member of MIT’s venture mentoring service and an advisor to MIT community life science entrepreneurs.